IHA Daily Briefing: January 30

Show Your Support During 340B Action Day on Feb. 1
Protecting and strengthening the 340B Drug Pricing Program remains one of IHA's most urgent legislative priorities. HB 2371 -which passed the Senate unanimously-now awaits final action in the House. Whether this legislation advances will depend, in large part, on the level of visible, on-the-ground engagement lawmakers see from hospitals and the communities they serve.

340B Action Day on Sunday, Feb. 1, in Chicago is a critical opportunity to do exactly that. This event, led by community advocates in partnership with local Federally Qualified Health Centers and hospitals, will elevate the real-world impact of the 340B program at a decisive moment in the legislative process. Healthcare providers and community leaders will share firsthand stories demonstrating how 340B expands access to care, sustains critical services, and supports Illinois' most vulnerable populations. Click here to view the informational event invitation.

The hospital community continues to face an intense and well-funded effort by pharmaceutical manufacturers to weaken the 340B program and stall progress in Springfield. This opposition is organized, aggressive, and persistent. It is essential that policymakers hear just as clearly-and just as forcefully-from the hospitals, providers, patients, and communities that rely on 340B every day.

We strongly urge hospitals to actively engage and mobilize staff, patients, community partners, and local legislators-and to encourage their participation on Feb. 1. A strong, diverse turnout is essential to sending an unmistakable message: Illinois hospitals and communities stand united behind HB 2371 and action is needed now.

Staff contact: Jordan Powell

CMS Finalizes Medicaid Tax Non-Uniformity Rule
The Centers for Medicare & Medicaid Services (CMS) issued a final rule addressing non-uniform or non-broad-based healthcare related Medicaid taxes. Essentially implementing provisions of the One Big Beautiful Bill Act (OBBBA), the rule prohibits states from levying higher tax rates on Medicaid-related businesses compared with the rate levied on non-Medicaid businesses, zeroing in on Medicaid managed care organizations and healthcare providers. The rule also incorporates the transition periods of up to three years established in OBBBA and referenced in the Dear Colleague letter issued by CMS on Nov. 14, 2025.

IHA is reviewing the rule and will communicate additional details to members in the coming weeks. CMS published a fact sheet, available here.

REGISTER: HNI Legislator Roundtable Feb. 18 in Springfield
Health News Illinois (HNI) will kick off its 2026 Event Series with a Feb. 18 Legislator Roundtable in Springfield. Held the day of Gov. JB Pritzker's joint State of the State and Budget Address, HNI will gather legislative leaders for a panel focused on what they see as the top health issues of the spring 2026 legislative sessions. Panelists include:

• Rep. Anna Moeller

• Rep. Norine Hammond

• Sen. Omar Aquino

• Sen. Dave Syverson

Click here to register for the program. The in-person event will be held at the Inn at 835, 835 S. 2nd Street in Springfield. Registration and networking will begin at 7:15 a.m. CT, and the discussion will begin at 7:45 a.m. CT.

New Video Offers Guidance on 'Cyber Typhoon' Threat to Health Sector
Chinese-backed cyber operatives, often referred to as cyber typhoons, represent one of the most serious emerging risks in the healthcare and public health sector.

The U.S. Dept. of Health and Human Services' 405(d) Cyber Program has published a new educational Typhoon video to inform the healthcare sector about the cyberthreat. The video breaks down the danger these threat actors pose to organizations of all sizes and provides clear, foundational guidance for leaders, IT teams, and other professionals. By outlining how these state-sponsored actors operate and the vulnerabilities they commonly target, the video serves as an accessible starting point for preserving patient safety, continuity of care, and critical infrastructure protection.

Recall Alerts: Stents, Vaporizers, Anesthesia Circuits and Medical Tape
The Food and Drug Administration (FDA) recently issued several Class I recall alerts, the most serious type of recall because use of the device or product may cause serious injury or death. Recent recalls include:

• Olympus recommends certain High Flow Insufflation Units be removed due to overpressure events that have already caused two serious injuries.

• Integra LifeSciences identified packing issues with all MediHoney Wound and Burn products and certain lots of CVS Wound Gel that could lead to patient infection and delays in care; fourteen serious injuries have been caused by these issues.

• Boston Scientific recommends removal of certain stents and electrocautery enhanced delivery systems. There have been 167 serious injuries and three deaths associated with this issue.

• Draeger recommends use of certain Vapor 2000 and Vapor 3000 products be discontinued due to the potential patients may ingest or inhale dangerous impurities.

• Medline recommends use of certain Anesthesia Circuit Kits and Anesthesia Circuits be discontinued following complaints of leakage.

• AirLife recommends use of certain Broselow Rainbow Tapes be discontinued due to labeling error that identify incorrect doses.

Illinois Respiratory Disease Surveillance Data